The efficacy and safety of combined immune checkpoint inhibitors (nivolumab plus ipilimumab): a systematic review and meta-analysis

被引：0
作者：
Jingjie Chen
Shengnan Li
Qigu Yao
Nannan Du
Xiaojun Fu
Yuanmei Lou
Mengru Wang
Feiyan Mao
Danyi Mao
Parikshit Asutosh Khadaroo
Yingying Tang
机构：
[1] University of Chinese Academy of Sciences,Department of General Surgery, HwaMei Hospital
[2] University of Chinese Academy of Sciences,Ningbo Institute of Life and Health Industry
[3] Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province,The Second Clinical Medical College
[4] Zhejiang Chinese Medical University,State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine
[5] Zhejiang University,The Third Clinical Medical College
[6] Zhejiang Chinese Medical University,Basic Medical College
[7] Medical College of Kaifeng University,Monash University School of Medicine
[8] Zhejiang Chinese Medical University,Department of Radiotherapy and Chemotherapy, HwaMei Hospital
[9] Nursing and Health Sciences,undefined
[10] University of Chinese Academy of Sciences,undefined
来源：
World Journal of Surgical Oncology | / 18卷
关键词：
Nivolumab; Ipilimumab; Tumor response; Adverse events; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 362 条
[1]  
Fife BT(2008)Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways Immunological reviews 224 166-182
[2]  
Bluestone JA(2001)Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses Nature 410 608-611
[3]  
Stamper CC(2008)CTLA-4 control over Foxp3+ regulatory T cell function Science (New York, NY) 322 271-275
[4]  
Zhang Y(2010)The PD-1 pathway in tolerance and autoimmunity Immunological reviews 236 219-242
[5]  
Tobin JF(2015)The next immune-checkpoint inhibitors: PD-1/PD-L1 blockade in melanoma Clin Ther 37 764-782
[6]  
Erbe DV(2019)Immune checkpoint blockade in small cell lung cancer Lung cancer (Amsterdam, Netherlands) 137 31-37
[7]  
Ikemizu S(2016)Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy Clinical advances in hematology & oncology : H&O 14 922-933
[8]  
Davis SJ(2018)Combination immune checkpoint blockade strategies to maximize immune response in gynecological cancers Current oncology reports 20 94-1545
[9]  
Stahl ML(2019)Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies American journal of cancer research 9 1536-128
[10]  
Seehra J(2015)Immunotherapy of melanoma: present options and future promises Cancer Metastasis Rev 34 115-83
12345678910